<< Hospice in nursing homes can provide high quality end-of-life care and other benefits: Study | New Magna Pure 96 System from Roche Applied Science >>
Read in | English | Finnish

Baxa launches new pricing model for IntelliFlowRx and Intellifill I.V. without capital investment

Published on October 1, 2009 at 2:29 AM · No Comments

Baxa Corporation announces the launch of a new program for sourcing its IntelliFill i.v. Automation and IntelliFlowRx Pharmacy Workflow Manager products. The Baxa IntelliSource(TM) program offers health-system pharmacies access to the automation and software they need to ensure that each dose dispensed is safe and accurate - without making capital investments, paying one-time setup fees or signing capital leases.

"Our goal was to make it easy for health systems to improve their pharmacy operations," notes Greg Baldwin, Baxa CEO. "We feel that patient safety improvements shouldn't take a back seat to this economy's capital crunch. The IntelliSource pricing model makes it easy for health systems to install the latest pharmacy technology, eliminating the need for capital investment and providing manageable monthly fees for access."

Using the IntelliSource model, health systems can implement the IntelliFlowRx pharmacy workflow manager without capital expenditures or lump-sum setup charges. This allows facilities of all sizes the ability to use barcode drug identification, automated dose preparation workflow management and dose checking safety features provided by IntelliFlowRx. In addition, the Baxa IntelliSource program makes it easy for health systems to get started. Once consultation on pharmacy workflow is completed, systems can be installed without the lengthy delays associated with capital allocation procedures.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading